Enhanced negative priming in Parkinson's disease

Area of Science:

• Cognitive Neuroscience
• Neuropsychology
• Movement Disorders

Background:

• Negative priming (NP) measures the cognitive cost of ignoring irrelevant stimuli.
• Parkinson's disease (PD) involves dopamine system degeneration, potentially impacting cognitive functions like inhibitory control.
• Understanding NP in PD can elucidate the role of dopamine in cognitive processing and response selection.

Purpose of the Study:

• To investigate negative priming (NP) effects in individuals with Parkinson's disease (PD) compared to healthy controls (HCs).
• To examine whether NP effects differ between response initiation and response execution phases.
• To explore the relationship between NP magnitude and clinical motor symptoms in PD.

Main Methods:

• Utilized an ignored repetition task on a touchscreen interface.
• Tested 25 participants with PD and 17 age-matched HCs.
• Partitioned response time into initiation and execution components to analyze NP effects.

Main Results:

• Both PD and HC groups showed larger NP effects in response execution than initiation.
• The PD group exhibited significantly larger overall NP effects compared to the HC group.
• In PD, greater bradykinesia severity correlated with larger NP effects, while tremor severity did not.

Conclusions:

• Parkinson's disease is associated with enhanced negative priming, indicating impaired ability to disengage from previously ignored stimuli.
• Dopamine deficiency in PD appears to reduce response efficiency, particularly when re-engaging with ignored information.
• These findings highlight the critical role of dopaminergic neuromodulation in cognitive control and action selection.